[go: up one dir, main page]

NO20056238L - Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid - Google Patents

Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid

Info

Publication number
NO20056238L
NO20056238L NO20056238A NO20056238A NO20056238L NO 20056238 L NO20056238 L NO 20056238L NO 20056238 A NO20056238 A NO 20056238A NO 20056238 A NO20056238 A NO 20056238A NO 20056238 L NO20056238 L NO 20056238L
Authority
NO
Norway
Prior art keywords
alpha
preparation
eletriptan hydrobromide
feeder
enhanced
Prior art date
Application number
NO20056238A
Other languages
English (en)
Inventor
Ronald James Ogilvie
Patrick Joseph Furlong
Cornelius Joseph Kelly
Vincent Ryan
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27772518&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20056238(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of NO20056238L publication Critical patent/NO20056238L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Forehggende oppflimelse tilveiebringer en forbedret fremgangsmåte for fremstilling av a-polymorf eletriptanhydrobomid.
NO20056238A 2003-07-23 2005-12-30 Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid NO20056238L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0317229.3A GB0317229D0 (en) 2003-07-23 2003-07-23 Improved process
PCT/IB2004/002322 WO2005007649A1 (en) 2003-07-23 2004-07-12 Improved process for preparing alpha-polymorphic eletriptan hydrobromide

Publications (1)

Publication Number Publication Date
NO20056238L true NO20056238L (no) 2006-04-05

Family

ID=27772518

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056238A NO20056238L (no) 2003-07-23 2005-12-30 Forbedrede mater for fremstilling av Alfa-Polymorfisk Eletriptanhydrobromid

Country Status (25)

Country Link
EP (1) EP1660485B1 (no)
JP (1) JP2006528172A (no)
KR (1) KR100694962B1 (no)
CN (1) CN100430388C (no)
AR (1) AR046509A1 (no)
AT (1) ATE349442T1 (no)
AU (1) AU2004256994A1 (no)
BR (1) BRPI0412721A (no)
CA (1) CA2532111A1 (no)
CO (1) CO5650232A2 (no)
CY (1) CY1105980T1 (no)
DE (1) DE602004003966T2 (no)
DK (1) DK1660485T3 (no)
ES (1) ES2274473T3 (no)
GB (1) GB0317229D0 (no)
IL (1) IL172765A0 (no)
MX (1) MXPA06000793A (no)
NO (1) NO20056238L (no)
NZ (1) NZ544305A (no)
PL (1) PL1660485T3 (no)
PT (1) PT1660485E (no)
RU (1) RU2320655C2 (no)
TW (1) TWI291956B (no)
WO (1) WO2005007649A1 (no)
ZA (1) ZA200600607B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101139557B1 (ko) 2003-07-23 2012-04-30 바이엘 파마슈티칼스 코포레이션 질환 및 상태의 치료 및 예방을 위한 플루오로 치환오메가-카르복시아릴 디페닐 우레아
JP5214124B2 (ja) 2006-08-17 2013-06-19 三星電子株式会社 通信システム、通信装置、尤度計算方法、及びプログラム
US20090299077A1 (en) * 2008-05-22 2009-12-03 Vinod Kumar Kansal Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan
WO2010116386A2 (en) * 2009-04-08 2010-10-14 Biophore India Pharmaceuticals Pvt. Ltd. Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
IT1393700B1 (it) * 2009-04-22 2012-05-08 F S I Fabbrica Italiana Sint Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo
WO2011004391A2 (en) * 2009-06-25 2011-01-13 Matrix Laboratories Ltd An improved process for the preparation of eletriptan and its salt thereof
WO2011089614A1 (en) * 2010-01-19 2011-07-28 Sms Pharmaceuticals Limited PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
WO2012004811A1 (en) * 2010-07-06 2012-01-12 Ind-Swift Laboratories Limited Process for the preparation of 5-substsituted indole derivative
CN102786514B (zh) * 2012-07-26 2014-01-29 武汉人福医药集团股份有限公司 依来曲普坦的制备方法
CN104341397A (zh) * 2013-07-31 2015-02-11 上海威智医药科技有限公司 具晶型的依来曲普坦自由碱及其制法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW288010B (no) * 1992-03-05 1996-10-11 Pfizer
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU3217295A (en) * 1994-08-12 1996-03-07 Donald D. II Thomas Miniaturized blood pressure monitor kit
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB0031094D0 (en) * 2000-12-20 2001-01-31 Pfizer Ltd New Process

Also Published As

Publication number Publication date
NZ544305A (en) 2008-09-26
RU2320655C2 (ru) 2008-03-27
AR046509A1 (es) 2005-12-14
MXPA06000793A (es) 2006-04-07
ES2274473T3 (es) 2007-05-16
ZA200600607B (en) 2007-05-30
KR100694962B1 (ko) 2007-03-14
TW200510388A (en) 2005-03-16
CA2532111A1 (en) 2005-01-27
RU2006101689A (ru) 2006-06-27
TWI291956B (en) 2008-01-01
AU2004256994A1 (en) 2005-01-27
KR20060030118A (ko) 2006-04-07
DK1660485T3 (da) 2007-03-19
PL1660485T3 (pl) 2007-04-30
JP2006528172A (ja) 2006-12-14
WO2005007649A1 (en) 2005-01-27
BRPI0412721A (pt) 2006-09-26
IL172765A0 (en) 2006-04-10
EP1660485B1 (en) 2006-12-27
CN100430388C (zh) 2008-11-05
EP1660485A1 (en) 2006-05-31
DE602004003966T2 (de) 2007-05-24
CN1823060A (zh) 2006-08-23
DE602004003966D1 (de) 2007-02-08
PT1660485E (pt) 2007-01-31
ATE349442T1 (de) 2007-01-15
CY1105980T1 (el) 2011-04-06
CO5650232A2 (es) 2006-06-30
GB0317229D0 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
IL172357A0 (en) Method for the production of substituted 3-aryl-butyl amine compounds
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
MXPA02012795A (es) Carvedilol.
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
MX2009009773A (es) Sintesis de gamma-carbolinas fusionadas con heterociclo substituido.
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
SE0203713D0 (sv) Novel compounds
CY1109006T1 (el) Παραγωγα πουρινης ως αναστολεις κινασης
BRPI0414599A (pt) pirrol-indóis substituìdos
MX2007005221A (es) Formas cristalinas de ascomicina y preparacion de ellas.
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
TW200617019A (en) A process for the preparation of 7α-alkylated 19-norsteroids
MXPA05013202A (es) Tableta de multiples capas oralmente dispersable.
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
NO20074047L (no) Ny fremgangsmate for fremstilling av substituerte indoler
HRP20150163T1 (xx) Postupak za proizvodnju n-supstituiranih 2-cijanopirolidina
MY138826A (en) 2,7-substituted indoles
MX2007010375A (es) Preparacion de quinoxalina sustituida de elevada pureza.
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MX2007003471A (es) Nueva forma cristalina de clorhidrato de (3-cian-1h-indol-7-il)-[4 -(4-fluorofenetil)-piperazin-1-il]-metanona.
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application